Stocks of Dyne Therapeutics Inc (NASDAQ:DYN) traded higher last session on Wall Street, up 3.00% to $8.94.
DYN stock price is now -23.83% away from the 50-day moving average and -53.79% away from the 200-day moving average. The market capitalization of the company currently stands at $1.02B.
With the price target of $13, Bernstein recently initiated with Mkt Perform rating for Dyne Therapeutics Inc (NASDAQ: DYN). , while ‘Oppenheimer’ rates the stock as ‘Outperform’
In other news, Scalzo Richard William, Officer bought 1,330 shares of the company’s stock on Jun 11 ’25. The stock was bought for $19,619 at an average price of $14.75. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 11 ’25, Officer Beskrovnaya Oxana bought 2,132 shares of the business’s stock. A total of $31,449 was incurred on buying the stock at an average price of $14.75. A total of 25.01% of the company’s stock is owned by insiders.
During the past 12 months, Dyne Therapeutics Inc has had a low of $6.36 and a high of $47.45. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 20.35, and a quick ratio of 20.35. The fifty day moving average price for DYN is $11.7367 and a two-hundred day moving average price translates $19.346125 for the stock.
The latest earnings results from Dyne Therapeutics Inc (NASDAQ: DYN) was released for 2025-03-31.
